Efanesoctocog alfa 2,000unit powder and solvent for solution for injection vials
NHS hospitals in England used £19,161,600 of indicative cost of Efanesoctocog alfa 2,000unit powder and solvent for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Efanesoctocog alfa 2,000unit powder and solvent for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Efanesoctocog alfa 2,000unit powder and solvent for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £9,427,200 |
| Barts Health Nhs Trust | £3,105,600 |
| East Kent Hospitals University Nhs Ft | £2,289,600 |
| Nottingham University Hospitals Trust | £1,137,600 |
| Guy's & St Thomas' Nhs Foundation Trust | £960,000 |
| Sheffield Teaching Hospitals Nhs Trust | £523,200 |
| Univ Hpl B/Ham Nhs Foundation Trust | £374,400 |
| Sheffield Children's Nhs Ft | £297,600 |
| University Hpls Of Leicester Nhs Trust | £268,800 |
| Derby Teaching Hospitals Nhs Found Trust | £220,800 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.